Avenue Therapeutics, Inc. - ATXI

SEC FilingsOur ATXI Tweets

About Gravity Analytica

Recent News

  • 01.06.2026 - SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership
  • 01.06.2026 - 4 - Statement of changes in beneficial ownership of securities
  • 12.31.2025 - 8-K - Current report
  • 12.17.2025 - EFFECT - Notice of Effectiveness
  • 12.15.2025 - POS AM - Post-effective amendment to a registration statement that is not immediately effective upon filing
  • 12.15.2025 - RW - Registration Withdrawal Request
  • 12.05.2025 - DEF 14A - Definitive proxy statements
  • 11.18.2025 - 8-K - Current report
  • 11.13.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
  • 11.12.2025 - 8-K - Current report

Recent Filings

  • 12.31.2025 - 8-K Current report
  • 12.16.2025 - EFFECT Notice of Effectiveness
  • 12.15.2025 - RW Registration Withdrawal Request
  • 12.15.2025 - POS AM Post-Effective amendments for registration statement
  • 12.05.2025 - DEF 14A Other definitive proxy statements
  • 11.18.2025 - 8-K Current report
  • 11.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 11.12.2025 - 8-K Current report
  • 11.12.2025 - EX-99.1 EX-99.1